• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从大肠杆菌中纯化和鉴定重组纤溶酶原激活物抑制剂-1

Purification and characterization of recombinant plasminogen activator inhibitor-1 from Escherichia coli.

作者信息

Reilly T M, Seetharam R, Duke J L, Davis G L, Pierce S K, Walton H L, Kingsley D, Sisk W P

机构信息

E. I. du Pont de Nemours and Company, Medical Products Department, Wilmington, Delaware 19880-0400.

出版信息

J Biol Chem. 1990 Jun 5;265(16):9570-4.

PMID:2188980
Abstract

A recombinant form of plasminogen activator inhibitor-1 (rPAI-1) has been purified from lysates of pCE1200, a bacterial expression vector containing the full length PAI-1 gene, by utilizing sequential anion exchange and cation exchange chromatography on Q-Sepharose and S-Sepharose columns. Approximately 140 mg of rPAI-1, estimated at 98% purity on the basis of analytical high performance liquid chromatography, could be obtained from 200 g wet weight of cells. The purified protein exhibited a single Coomassie Blue-stainable band at the region of Mr = 42,000 by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and an NH2-terminal amino acid sequence consistent with the expected translation product of the pCE1200 PAI-1 insert. The rPAI-1 rapidly inhibited single- and two-chain tissue plasminogen activators, as well as urokinase, with apparent second order rate constants in the range of 2-5 x 10(7) M-1 s-1. A specific activity measurement of 250,000 units/mg was calculated for the rPAI-1 based on its ability to inhibit the enzymatic activity of a single-chain tissue plasminogen activator. Stability studies showed that the activity of the rPAI-1 was very stable when stored at temperatures of 25 degrees C or lower, but decayed within hours when stored at 37 degrees C. Sodium dodecyl sulfate treatment, which partially activates the latent form of natural PAI-1, inactivated rPAI-1. These results show that the purified rPAI-1 produced from pCE1200 displays many of the properties associated with the biologically active form of natural PAI-1.

摘要

一种重组形式的纤溶酶原激活物抑制剂-1(rPAI-1)已从pCE1200的裂解物中纯化出来,pCE1200是一种含有全长PAI-1基因的细菌表达载体,通过在Q-琼脂糖和S-琼脂糖柱上依次进行阴离子交换和阳离子交换色谱法。基于分析型高效液相色谱法估计纯度为98%,从200克湿重的细胞中可获得约140毫克的rPAI-1。通过十二烷基硫酸钠-聚丙烯酰胺凝胶电泳,纯化的蛋白质在Mr = 42,000区域呈现出一条考马斯亮蓝可染色带,其氨基末端氨基酸序列与pCE1200 PAI-1插入片段的预期翻译产物一致。rPAI-1能迅速抑制单链和双链组织纤溶酶原激活物以及尿激酶,其表观二级速率常数在2 - 5×10⁷ M⁻¹ s⁻¹范围内。基于其抑制单链组织纤溶酶原激活物酶活性的能力,计算出rPAI-1的比活性为250,000单位/毫克。稳定性研究表明,rPAI-1在25℃或更低温度下储存时活性非常稳定,但在37℃储存时几小时内就会衰减。十二烷基硫酸钠处理可部分激活天然PAI-1的潜伏形式,但会使rPAI-1失活。这些结果表明,从pCE1200产生的纯化rPAI-1具有许多与天然PAI-1生物活性形式相关的特性。

相似文献

1
Purification and characterization of recombinant plasminogen activator inhibitor-1 from Escherichia coli.从大肠杆菌中纯化和鉴定重组纤溶酶原激活物抑制剂-1
J Biol Chem. 1990 Jun 5;265(16):9570-4.
2
Purification of active human plasminogen activator inhibitor 1 from Escherichia coli. Comparison with natural and recombinant forms purified from eucaryotic cells.
Eur J Biochem. 1989 Dec 22;186(3):523-33. doi: 10.1111/j.1432-1033.1989.tb15238.x.
3
Affinity purification of active plasminogen activator inhibitor-1 (PAI-1) using immobilized anhydrourokinase. Demonstration of the binding, stabilization, and activation of PAI-1 by vitronectin.使用固定化无水尿激酶亲和纯化活性纤溶酶原激活物抑制剂-1(PAI-1)。证明玻连蛋白对PAI-1的结合、稳定和激活作用。
J Biol Chem. 1989 May 15;264(14):7862-8.
4
Purification and characterisation of plasminogen activator inhibitor 2 produced in Saccharomyces cerevisiae.在酿酒酵母中产生的纤溶酶原激活物抑制剂2的纯化及特性分析
Eur J Biochem. 1991 Mar 14;196(2):431-8. doi: 10.1111/j.1432-1033.1991.tb15834.x.
5
Purification and characterization of active and latent forms of recombinant plasminogen activator inhibitor 1 produced in Escherichia coli.
Biochemistry. 1992 Oct 20;31(41):9877-82. doi: 10.1021/bi00156a004.
6
Structural determinants of the noncatalytic chain of tissue-type plasminogen activator that modulate its association rate with plasminogen activator inhibitor-1.组织型纤溶酶原激活剂非催化链的结构决定因素,其调节与纤溶酶原激活剂抑制剂-1的结合速率。
J Biol Chem. 1990 Jun 25;265(18):10473-8.
7
Plasminogen activator inhibitor from human fibrosarcoma cells binds urokinase-type plasminogen activator, but not its proenzyme.来自人纤维肉瘤细胞的纤溶酶原激活物抑制剂能结合尿激酶型纤溶酶原激活物,而非其酶原。
J Biol Chem. 1986 Jun 15;261(17):7644-51.
8
Kinetic analysis of the interactions between plasminogen activator inhibitor 1 and both urokinase and tissue plasminogen activator.纤溶酶原激活物抑制剂1与尿激酶和组织纤溶酶原激活物之间相互作用的动力学分析
Arch Biochem Biophys. 1988 Apr;262(1):199-210. doi: 10.1016/0003-9861(88)90182-8.
9
Structural requirements for the extracellular interaction of plasminogen activator inhibitor 1 with endothelial cell matrix-associated vitronectin.纤溶酶原激活物抑制剂1与内皮细胞基质相关玻连蛋白细胞外相互作用的结构要求
J Biol Chem. 1990 Oct 25;265(30):18490-8.
10
Purification of high and low molecular weight plasminogen activator inhibitor 1 from fibrosarcoma cell-line HT 1080 conditioned medium.
Biochim Biophys Acta. 1989 Feb 23;994(3):253-7. doi: 10.1016/0167-4838(89)90301-4.